Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula granules in China. The company offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. It also offers health food, health products, functional health food, and daily chemical products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is headquartered in Xi'an, China.
Research context
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is currently in a long term downtrend where the price is trading 2.3% below its 200 day moving average.
From a valuation standpoint, the stock is 66.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's total revenue rose by 22.2% to $214M since the same quarter in the previous year.
Its net income has increased by 144.6% to $34M since the same quarter in the previous year.
Finally, its free cash flow grew by 136.9% to $23M since the same quarter in the previous year.
Based on the above factors, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd gets an overall score of 4/5.